Mark S Stein

Summary

Affiliation: Royal Melbourne Hospital
Country: Australia

Publications

  1. ncbi A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease
    Mark S Stein
    Royal Melbourne Hospital, Parkville, Vic, Australia Walter and Eliza Hall Institute of Medical Research, Parkville, Vic, Australia
    J Alzheimers Dis 26:477-84. 2011
  2. ncbi A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
    M S Stein
    Department of Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Neurology 77:1611-8. 2011

Collaborators

Detail Information

Publications2

  1. ncbi A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease
    Mark S Stein
    Royal Melbourne Hospital, Parkville, Vic, Australia Walter and Eliza Hall Institute of Medical Research, Parkville, Vic, Australia
    J Alzheimers Dis 26:477-84. 2011
    ..02), but may represent regression to the mean as WLS-R LM did not change. We conclude that high-dose vitamin D provides no benefit for cognition or disability over low-dose vitamin D in mild-moderate AD...
  2. ncbi A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
    M S Stein
    Department of Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Neurology 77:1611-8. 2011
    ..We therefore evaluated the effects of high-dose vitamin D2 (D2) in MS...